Target intelligence / Profile preview

α-mannan, fungal cell wall

Molecular classification
Other (polysaccharide cell wall component), Structural carbohydrate, Fungal cell wall biomacromolecule
01

Overview

**α-mannan** is a structural polysaccharide forming a major component of the outer layer of many fungal cell walls. It consists of repeating α-linked mannose residues (often α-1,6 and α-1,2 linkages) and may serve as a backbone for large, branched mannans, including galactomannan in *Aspergillus* species[2][4][5][6]. In yeasts like *Saccharomyces cerevisiae* and *Candida albicans*, α-mannan is typically highly branched and linked to glycoproteins, whereas in pathogenic molds like *Aspergillus fumigatus*, it forms part of more linear and complex glycans covalently bound to the glucan–chitin core of the cell wall[2][5]. α-mannan is critical for maintaining cell wall integrity, proper morphogenesis, and virulence of fungal pathogens. Its biosynthesis involves multiple mannosyltransferase enzymes; genetic disruption of these enzymes impairs fungal growth and reduces virulence, underscoring its value as an antifungal target[4]. Clinically, α-mannan (and related galactomannan) is released during invasive fungal infection and serves as a diagnostic biomarker, detectable in patient serum or urine by immunological assays[6]. Current antifungal drugs do not directly target α-mannan, but its biosynthetic enzymes (including core-mannan synthase) represent an active area of therapeutic investigation due to their essential roles and fungal specificity[4][6]. There are no major safety concerns for targeting α-mannan because it is not present in human cells, but diagnostic applications face limitations from biological variability. **Note:** α-mannan is not a classical receptor, ion channel, or enzyme, but a structural carbohydrate; its "target" status comes from its essential biological role and druggability of its biosynthetic enzymes. Also, galactomannan and other related mannans should not be conflated but are often measured or discussed together due to immunological cross-reactivity in diagnostics.

Other names
alpha-mannanfungal α-mannanmannan (fungal)fungal cell wall α-mannangalactomannan (related, but not identical)FTGM (fungal-type galactomannan; contains α-mannan core)
02

Mechanism of action

- Disruption of α-mannan biosynthesis (e.g., via inhibition of mannosyltransferases) leads to compromised wall integrity and fungal cell death or reduced virulence[4] - Immunological targeting for diagnostic and therapeutic use (e.g., antibody recognition of shed mannan in fluids)[6]

03

Biological functions

Structural scaffold for fungal cell wall integrity and rigidityRegulation of cell morphogenesis and growthMediates host immune evasion and immune recognitionInvolved in cell adhesion, spore formation, and hyphal elongation
04

Disease associations

Infection (central to fungal pathogenicity and recognized in invasive fungal diseases)Immune evasion in mycosesTarget for antifungal diagnostic biomarkers
05

Safety considerations

Polysaccharides like α-mannan are absent in humans, reducing the likelihood of off-target toxicity, but immune cross-reactivity can occur in rare casesDiagnostic limitations: release of mannan may vary with infection stage, fungal species, and host factors, leading to variable sensitivity and specificity[6]
06

Interacting drugs

Echinocandins (indirect interaction through alteration of wall components, not direct binding to mannan)

2 more in the full profile.

07

Biomarkers

Serum or urine α-mannan/galactomannan for detection of invasive fungal infections (notably aspergillosis, candidiasis)[6]Used in laboratory diagnostic immunoassays for mycoses

Beyond the preview

Go deeper on α-mannan, fungal cell wall.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on α-mannan, fungal cell wall.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call